Senator Tells FDA To Create ‘Red Team’ For Regulatory Streamlining
This article was originally published in The Pink Sheet Daily
HELP Committee Chairman Lamar Alexander wants FDA to suggest regs and other bureaucratic requirements that are hindering productivity as part of medical innovation effort.
You may also be interested in...
Senate legislation may be influenced by movement to push through Califf’s nomination for FDA commissioner.
Senate Health Committee continues work on its own 21st Century Cures-related legislation, meaning the newly passed House bill will be out of the spotlight for a bit.
CDER’s Woodcock says accelerated approval requirements in 21st Century Cures legislation could create a process akin to how FDA handles breakthrough designations.